![](/img/cover-not-exists.png)
9157 Retrospective review of efficiency of erlotinib or pemetrexed or docetaxel compared to docetaxel as subsequent line therapy in advanced non-small cell lung cancer (NSCLC) following failure of platinum-based chemotherapy
Almodovar, M.T., Luis, A., Ferreira, M.P., da Costa, J. DuroVolume:
7
Language:
english
Journal:
European Journal of Cancer Supplements
DOI:
10.1016/S1359-6349(09)71870-1
Date:
September, 2009
File:
PDF, 50 KB
english, 2009